Medroxyprogesterone Acetate Antikörper

Produktnummer ABIN487732

Produktdetails anti-Medroxyprogesterone Acetate Antikörper

Target: Medroxyprogesterone Acetate

Reaktivität: Bitte anfragen

Wirt: Schaf

Klonalität: Polyklonal

Konjugat: Dieser Medroxyprogesterone Acetate Antikörper ist unkonjugiert

Applikation: Enzyme Immunoassay (EIA)

Aufreinigung: Ig Fraction

Immunogen: Medroxyprogesterone acetate (3)-BTG

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA: 0.1 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 9.70mg/mL (U.V. abs at 280nm)

Buffer: 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Details zu Medroxyprogesterone Acetate

Target: Medroxyprogesterone Acetate

Abstract: Medroxyprogesterone Acetate Produkte

Substanzklasse: Chemical

Hintergrund: MPA (also known as depo provera) is a highly potent progestational steroid that has been used worldwide as a contraceptive. There has been a concern about the possibility of an increased risk of breast cancer associated with its use. On the other hand, MPA when employed at high doses (>0.5 - 1.0g / day i.m.) can produce objective remission with improved survival in about 30?% of postmenopausal women with advanced breast cancer resistant to cytotoxic drugs and endocrine therapies. Early results suggest that the response rate can be increased in patients with estrogen and / or progesterone positive receptors.Synonyms: MPA, Medroxy Progesterone Acetate, depo provera